News

Researchers have identified antibodies targeting a hard-to-spot region of the influenza virus, shedding light on the relatively unexplored 'dark side' of the neuraminidase (NA) protein head. The ...
NA proteins have globular heads on top of a thin stalk, and the head can tilt down more than 90 degrees, acting like a weedwhacker on a rotating axis. From these data, the researchers realized that as ...
The potential “tripledemic” of influenza, SARS-CoV-2 and RSV (respiratory syncytial virus) infection continues to be a concern. Vaccines remain the best defense against COVID-19 and influenza ...
The antibodies target a region of the NA protein that is common among many influenza viruses, including H3N2 subtype viruses, and could be a new target for countermeasures.
Their study in mice sheds light on the unexplored “dark side” of the neuraminidase (NA) protein head, that is common among many influenza viruses, including H3N2 subtype viruses, and could be ...
Influenza NA is a surface protein containing a globular head portion and a narrow stalk portion. The underside of the NA head contains a highly conserved region with targets for antibodies ...
There are many possible combinations of HA and NA proteins. The two known type A human influenza viruses are H1N1 and H3N2. (Two additional subtypes, H17N10 and H18N11, have been identified in bats).
NA proteins have globular heads on top of a thin stalk, and the head can tilt down more than 90 degrees, acting like a weedwhacker on a rotating axis. From these data, the researchers realized that as ...
Researchers at the National Institutes of Health have identified antibodies targeting a hard-to-spot region of the influenza virus, shedding light on the relatively unexplored “dark side” of ...
The potential “tripledemic” of influenza, SARS-CoV-2 and RSV (respiratory syncytial virus) infection continues to be a concern. Vaccines remain the best defense against COVID-19 and influenza, with ...
Vaccines remain the best defense against COVID-19 and influenza, with the flu vaccine mainly targeting two proteins on the virus’s surface. Researchers in ACS Central Science report that simulations ...